Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2000
10/05/2000WO2000058463A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000WO2000058460A2 Casb619 involved in colon cancers
10/05/2000WO2000058363A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
10/05/2000WO2000058358A1 49 human secreted proteins
10/05/2000WO2000058357A1 50 human secreted proteins
10/05/2000WO2000058350A1 49 human secreted proteins
10/05/2000WO2000058340A2 50 human secreted proteins
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058335A1 47 human secreted proteins
10/05/2000WO2000058334A1 50 human secreted proteins
10/05/2000WO2000058321A1 Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same
10/05/2000WO2000058312A1 Compounds capable of cleaving double-stranded dna and method of utilization of the same
10/05/2000WO2000058304A1 Heterocyclic sulfonamide derivatives
10/05/2000WO2000058280A1 Carbocyclic sulfonamide derivatives
10/05/2000WO2000058278A1 β-AMINO ACID DERIVATIVES
10/05/2000WO2000058271A1 Nitrogen mustard compounds and prodrugs therefor
10/05/2000WO2000057920A2 Method for expressing proteins
10/05/2000WO2000057917A2 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
10/05/2000WO2000057916A1 Sphingomyelin containing preparation for the enhancement of tumor therapy
10/05/2000WO2000057903A2 48 human secreted proteins
10/05/2000WO2000057901A1 Modulation of vascular permeability by means of tie2 receptor activators
10/05/2000WO2000057899A1 Thrombospondin-2 and uses thereof
10/05/2000WO2000057892A1 Use of a serenoa repens extract for the production of a medicament to treat prostate cancer
10/05/2000WO2000057878A1 Thiadiazolyl urea or thiourea derivatives for antiviral treatment
10/05/2000WO2000057875A1 Compositions containing tea catechins as cancer specific proliferation inhibitors
10/05/2000WO2000057874A1 A process for the preparation of aziridinyl epothilones from oxiranyl epothilones
10/05/2000WO2000057872A1 Z-styryl sulfone anticancer agents
10/05/2000WO2000057867A2 Improved cancer treatment with temozolomide
10/05/2000WO2000057865A2 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
10/05/2000WO2000057864A2 Cyclic glycerophosphates and analogs thereof
10/05/2000WO2000057861A2 Use of cytidine derivatives for the treatment of leukaemia
10/05/2000WO2000057860A2 Peroxovanadium compounds as antineoplastic agents for the treatment of cancer
10/05/2000WO2000057854A2 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances
10/05/2000WO2000057852A2 Methods and compositions for treating solid tumors
10/05/2000WO2000057705A1 In vitro induction of antigen-specific t-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens
10/05/2000WO2000031280A3 Use of plus-strand synthesis elements in retroviral vectors
10/05/2000WO2000029573A3 Adenoviral vectors
10/05/2000WO2000029033A3 A method of genetic vector delivery
10/05/2000WO2000028039A3 Identification of senv genotypes
10/05/2000WO2000026379A3 Polypeptide mediating cell permeability
10/05/2000WO2000026243A3 Transmembrane 4 proteins
10/05/2000DE19909373A1 Neue PNA-Monomere, daraus resultierende PNA-Oligomere und deren Verwendung New PNA monomers, resulting PNA oligomers and their use
10/05/2000CA2707691A1 Sphingomyelin containing preparation
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2370441A1 50 human secreted proteins
10/05/2000CA2369458A1 47 human secreted proteins
10/05/2000CA2368927A1 45 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368658A1 A process for the preparation of aziridinyl epothilones from oxiranyl epothilones
10/05/2000CA2368657A1 Thrombospondin-2 and uses thereof
10/05/2000CA2368597A1 Pharmaceutical compositions comprising cyclic glycerophosphates and analogs thereof for promoting neural cell differentiation
10/05/2000CA2368482A1 50 human secreted proteins
10/05/2000CA2368477A1 Polynucleotide and deduced amino acid sequences from stromal cells
10/05/2000CA2368469A1 50 human secreted proteins
10/05/2000CA2368467A1 50 human secreted proteins
10/05/2000CA2368442A1 48 human secreted proteins
10/05/2000CA2368374A1 47 human secreted proteins
10/05/2000CA2368302A1 49 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2368113A1 Protozoan expression system
10/05/2000CA2368014A1 Casb619 involved in colon cancers
10/05/2000CA2367901A1 Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
10/05/2000CA2366305A1 Method for expressing proteins
10/05/2000CA2366012A1 Methods of treating leukemia
10/05/2000CA2365995A1 Cyclic glycerophosphates and analogs thereof
10/05/2000CA2365122A1 Peroxovanadium compounds as antineoplastic agents for the treatment of cancer
10/05/2000CA2364622A1 Nitrogen mustard compounds and prodrugs therefor
10/05/2000CA2363716A1 49 human secreted proteins
10/05/2000CA2323140A1 Platinum complex conjugated to cyclotriphosphazene, its preparation, and anticancer agent comprising the same
10/04/2000EP1041083A1 Modified timp
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1040838A1 Stable aqueous EM 12 solution
10/04/2000EP1040198A1 Recombinant rhabdovirus containing a heterologous fusion protein
10/04/2000EP1040194A1 Human signal transduction serine/threonine kinase
10/04/2000EP1040187A2 Human protein kinase and kinase inhibitors
10/04/2000EP1040123A2 Human papillomavirus vaccine
10/04/2000EP1040119A2 Hemiasterlin analogs
10/04/2000EP1040118A1 Secreted proteins and polynucleotides encoding them
10/04/2000EP1040112A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/04/2000EP1040111A1 Integrin receptor antagonists
10/04/2000EP1040100A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
10/04/2000EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
10/04/2000EP1040098A1 Integrin receptor antagonists
10/04/2000EP1039937A2 Novel sterilization process for pharmaceutical suspensions
10/04/2000EP1039930A2 Adjuvanted vaccine formulation
10/04/2000EP1039926A1 Venezuelan equine encephalitis virus vectors expressing tumor-associated antigens to induce cancer immunity
10/04/2000EP1039925A1 Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells
10/04/2000EP1039922A1 Improved interferon polymer conjugates
10/04/2000EP1039908A1 Molecular dispersion composition with enhanced bioavailability
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000EP1039887A1 Methods for treatment of neuro- and nephro-disorders and therapeutic toxicities using aminothiol compounds
10/04/2000EP1019040A4 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/04/2000EP0699236B1 Purified mammalian flt3 ligands and agonists and antagonists thereof
10/04/2000CN1269013A Moleculars withch give out multiple active parts
10/04/2000CN1268953A Ligand for herps simplex virus entry mediator and method of use
10/04/2000CN1268948A Optically pure camptothecin analogues, optically pure synthessi intermdidate and method for preparing same
10/04/2000CN1268514A Tumor-inhibiting action of antisense nucleic acid against protein kinase gene
1 ... 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 ... 2211